For example, California, citing budget constraints, put Wegovy on a waiting list and limited it only to patients with certain co-conditions while studying overall impact
Siliphos: Highly bioavailable milk thistle extract that promotes liver function and naturally elevates glutathione levels.*
The FDA also approves this medicine to reduce the risk of major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) in adults with Type 2 diabetes and cardiovascular disease or multiple risk factors for heart disease
Bode BW, Brett J, Falahati A, Pratley RE
However, definitive evidence from adequately powered human trials demonstrating cognitive benefits is still lacking, and ongoing phase 3 studies are investigating these potential effects
Inspection report (Form FDA 483) sent August 2, 2024FDA Warning: Drug products failed to meet the requirements of approved outsourcing facilities under Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act): Current good manufacturing practice (cGMP) violations resulted in adulterated drug products